Manufacturing Facility

Cunningham Pharmaceuticals has developed state of the art cGMP production facility in Pakistan to ensure the production of the highest quality products to cater the local and International needs. The manufacturing facility is designed by highly experienced consultants and engineers having a vast experience of setting up GMP compliant manufacturing facilities for renowned local and multinational companies.

This production facility is presently in the commissioning phase. This modern production facility was designed keeping in view the principles of cGMP, efficient production control, quality assurance, industrial safety, occupational health and environmental control systems. This is to ensure that every product bearing the name of Cunningham Pharmaceuticals meets the highest international quality standards of production, safety and efficacy.

MANUFACTURING FACILITY


  • Total area 8 Kanals 37,212 sq ft.
  • Total covered Area 56,309 sq ft.
  • Established in 2016
  • License No. 000840, date of Issuance w.e.f 01-06-2016
  • General tablet
  • General Capsules
  • Sachet
  • QC and Microbiological Lab
  • Ware Houses
  • Cephalosporin Capsule
  • Cephalosporin Dry Powder Suspension
  • Cephalosporin Dry Powder Injection
  • General Ophthalmic drops
  • Steroidal Ophthalmic drops
  • Psychotropic Liquid injection
  • Psychotropic Tablets and Capsules